secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeStance Health Group, Inc. (LFST)
CIK:        0001845257
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0000950170-25-104363
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeStance Q2 revenue $345.3M (+11% YoY); raises FY 2025 Adj. EBITDA guidance to $140-150M
--------------------------------------------------------------------------------

- Revenue of $345.3M (+11% YoY); net loss narrowed to $3.8M from $23.3M.
- Adjusted EBITDA of $34.0M (+19% YoY); Free Cash Flow of $56.6M, a quarterly record.
- Clinician base grew 11% to 7,708 (net +173 in Q2); visit volumes up 12% to 2.2M.
- FY 2025 guidance: Adj. EBITDA raised to $140-150M (midpoint +$5M); revenue reiterated $1.40-1.44B.
- Q3 2025 guidance: revenue $345-365M, Adj. EBITDA $33-39M, Center Margin $105-119M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845257/000095017025104363/0000950170-25-104363-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845257/000095017025104363/lfst-20250807.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-104363

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer